Expressions of chemokines, including CCR5 and CCR6, suggest that EpCAM+ CD4+ T cells are directed to the tumor sites, which is corroborated in this study through IF and IMC, as shown in Figures 4C, 6A. This evidence concerns the gene CCR6 and neoplasm.